Zivo Bioscience, Inc. Announces 2024 Annual Meeting of Shareholders

TL;DR

<b>Zivo Bioscience, Inc. will hold its 2024 Annual Meeting of Shareholders on June 11, 2024, to elect a director, ratify auditors, and vote on executive compensation.</b>

AI Summary

Zivo Bioscience, Inc. (ZIVOW) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. Annual Meeting scheduled for June 11, 2024, at 10:00 a.m. ET in Pontiac, MI. Shareholders will vote on electing one Class II director. The appointment of the independent registered public accounting firm for FY 2024 will be ratified. Shareholders will provide an advisory vote on the compensation of named executive officers. Record date for shareholder eligibility to vote is April 12, 2024.

Why It Matters

For investors and stakeholders tracking Zivo Bioscience, Inc., this filing contains several important signals. Shareholders have the opportunity to influence board composition by electing a Class II director. The meeting allows shareholders to provide feedback on executive compensation through an advisory vote.

Risk Assessment

Risk Level: — Zivo Bioscience, Inc. shows moderate risk based on this filing. The filing is a routine proxy statement for an annual shareholder meeting, with no immediate financial or operational changes indicated.

Analyst Insight

Shareholders should review the proxy materials to make informed decisions regarding director elections and executive compensation.

Key Numbers

• June 11, 2024 — Annual Meeting Date (Date of the 2024 Annual Meeting of Shareholders)
• 10:00 a.m. Eastern Time — Meeting Time (Time of the 2024 Annual Meeting of Shareholders)
• April 12, 2024 — Record Date (Close of business date for determining shareholders entitled to vote)

Key Players & Entities

• Zivo Bioscience, Inc. (company) — Registrant
• June 11, 2024 (date) — Annual Meeting date
• April 12, 2024 (date) — Record date for shareholders
• Class II director (director) — Director to be elected

FAQ

Industry Context

Zivo Bioscience operates in the biotechnology sector, focusing on biological products.

Regulatory Implications

The filing is made under Section 14(a) of the Securities Exchange Act of 1934, governing proxy solicitations.

What Investors Should Do

1. Review the list of director nominees and their qualifications.
2. Understand the proposals regarding auditor ratification and executive compensation.
3. Ensure your vote is cast by the deadline or attend the meeting.

Key Dates

• 2024-06-11: Annual Meeting of Shareholders — Shareholders will vote on key corporate matters including director elections and executive compensation.
• 2024-04-12: Record Date — Determines which shareholders are eligible to vote at the Annual Meeting.

Year-Over-Year Comparison

This is a DEF 14A filing, indicating a definitive proxy statement for an upcoming annual meeting, which is a standard corporate governance document.

Key Financial Figures

• $0.001 — 8 shares of our common stock, par value $0.001 (the "Common Stock"). A shareholder is

Filing Documents

• zivo_def14a.htm (DEF 14A) — 457KB
• zivo_def14aimg10.jpg (GRAPHIC) — 29KB
• zivo_def14aimg16.jpg (GRAPHIC) — 1KB
• zivo_def14aimg17.jpg (GRAPHIC) — 1KB
• zivo_def14aimg18.jpg (GRAPHIC) — 1KB
• zivo_def14aimg19.jpg (GRAPHIC) — 1KB
• zivo_def14aimg9.jpg (GRAPHIC) — 28KB
• 0001654954-24-005060.txt (&nbsp;) — 544KB

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 15 PAY-VERSUS-PERFORMANCE 19

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS 22 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS 24 PROPOSAL NO. 2 - RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 27 PROPOSAL NO. 3 - ADVISORY VOTE ON NAMED EXECUTIVE OFFICER COMPENSATION 28 OTHER MATTERS 29 5 Table of Contents QUESTIONS AND ANSWERS Q: What may I vote on? A. You may vote on the following proposals: 1. ELECTION OF DIRECTORS There is one nominee for election to the Company's Board this year: one Class II director named in the Proxy Statement to hold office until the 2027 annual meeting. The Board recommends a vote FOR the nominee. 2. RATIFICATION OF AUDITOR We are requesting that shareholders approve the ratification of the appointment of our independent registered public accounting firm for the fiscal year ending December 31, 2024. The Board recommends a vote FOR the ratification of the appointment of our independent registered public accounting firm for the fiscal year ending December 31, 2024. 3. ADVISORY VOTE ON EXECUTIVE COMPENSATION We are requesting that shareholders approve, on an advisory basis, the compensation of our named executive officers. The Board recommends a vote FOR the approval of the compensation of our named executive officers. Q: Who is entitled to vote? A: Shareholders of record as of the close of business April 12, 2024 are entitled to vote at the Annual Meeting. Q: How do I vote? A: Stockholders of Record. You may vote by internet, by phone or by completing, signing and returning the enclosed proxy card in the postage-paid envelope provided. To vote by internet or phone, you will need to use a control number provided to you in the materials with this proxy statement and follow the additional steps when prompted. The steps have been designed to authenticate your identity, allow you to give voting instructions, and confirm that those instructions have been

View Full Filing

View this DEF 14A filing on SEC EDGAR